| Identification | Back Directory | [Name]
Research Grade Semzuvolimab (DHB95908) | [CAS]
2409099-32-5 | [Synonyms]
Semzuvolimab
Research Grade Semzuvolimab (DHB95908) |
| Hazard Information | Back Directory | [Uses]
Semzuvolimab is a human IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Human CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2]. | [References]
[1] Wang Changyi, et al. Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients. World Intellectual Property Organization, WO2018035001 A1. 2018-02-22.
[2] Semzuvolimab. IMGT/mAb-DB. |
|
| Company Name: |
Biolab Reagents
|
| Telephone: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|